Rhythm Biosciences Limited (RHY) is an Australian medical diagnostics company on a mission to improve global healthcare by developing and commercializing innovative diagnostic technologies. They focus on creating simple, affordable tests for use in both domestic and international markets. Their flagship product, ColoSTAT, is currently in development and aims to be a game-changer in the fight against colorectal cancer by providing an accurate and early detection method through a simple blood test.